Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The immunological background to transplantation

M Haeney1

  • 1Department of Immunology, Salford Royal Hospitals NHS Trust, Hope Hospital, UK.

The Journal of Antimicrobial Chemotherapy
|October 1, 1995
PubMed
Summary

Organ transplant rejection occurs unless donors and recipients are genetically identical. T lymphocytes, particularly CD4+ T cells, recognize foreign antigens, initiating a systemic immune response that leads to graft rejection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent pure red cell aplasia due to parvovirus B19 infection in a patient with Turner's syndrome.

Clinical and laboratory haematology·2006
Same author

Sarcoidosis and HTLV-1 infection.

Journal of clinical pathology·2005
Same author

Primary antibody deficiency and diagnostic delay.

Journal of clinical pathology·2005
Same author

The role of fear of physical movement and activity in chronic fatigue syndrome.

Journal of psychosomatic research·2002
Same author

Setting standards for pathology service support to emergency services.

Journal of the Royal Society of Medicine·2001
Same author

The application of near patient testing to microbiology.

Communicable disease and public health·1999

Area of Science:

  • Immunology
  • Transplantation Biology

Background:

  • Organ transplantation is a clinical solution for irreversible organ dysfunction.
  • Graft rejection is a major hurdle, occurring when donor and recipient are not genetically identical.
  • Early tumor transplantation experiments revealed limitations, leading to the 'laws of transplantation'.

Observation:

  • Sir Peter Medawar's work confirmed rejection as a systemic, lymphocyte-governed process.
  • Studies on skin graft rejection in mice identified the major histocompatibility complex (MHC) antigens.
  • MHC antigens present processed antigens to T lymphocytes, crucial for immune recognition.

Findings:

  • T lymphocytes are central to transplant rejection.
  • The sensitization phase involves recipient CD4+ T cells recognizing foreign passenger leukocytes in the graft.
  • The effector phase involves activated T cells producing cytokines within the graft, driving rejection.

Implications:

  • Understanding T cell roles in rejection enhances knowledge of T cell physiology.
  • Preventing rejection has spurred the development of novel immunomodulating agents.
  • These immunomodulatory strategies have broader applications in treating various immunological disorders.

Related Experiment Videos